A federal appeals court has rejected Apple Inc.’s efforts to rid itself of a corporate monitor appointed in the wake of a judge’s finding the company liable for conspiring to raise the price of e-books.
April’s bond market squall has subsided. But by historical standards 10-year yields in the U.S., Germany and the U.K. remain extraordinarily low.
Hong Kong’s market regulator said it is investigating Chinese solar firm Hanergy—after the company’s chairman told Chinese media that a probe was “purely rumor.”
Miners want to sell off their mines, but they have a problem: Almost no one wants to buy them. Some veteran bankers in the mining industry are seeing the longest drought of deals in their careers.
Chinese stocks were rocked by a sharp selloff that left Shanghai 6.5% lower, a sudden reversal of fortune for one of the world’s top-performing markets this year.
A forward-looking gauge of U.S. home purchases rose for the fourth straight month in April and reached their highest level in nine years—the latest evidence of firming demand in the housing market.
Teva Pharmaceutical Industries will pay $1.2 billion to settle government allegations its Cephalon subsidiary paid generic-drug makers to delay competing versions of the sleep-disorder drug Provigil.
A year after Stryker eyed a deal to buy Smith & Nephew, the U.K. company is trying to disrupt the status quo in U.S. orthopedics. That is worth watching.
The FAA has set up an advisory group to consider possible changes in mental-health screening of U.S. commercial pilots.
Google this week will make a renewed push for developers to work with Android for wearable devices, Internet-connected TVs, cars and virtual reality at its I/O conference.